Header graphic for print
LimeGreenIP News

Category Archives: Patents

Subscribe to Patents RSS Feed

Wearable-tech turns luxury as designer brands collaborate with tech firms

In August’s issue of Jewellery Focus, Mark Marfé, a senior lawyer in our IPMT practice in London, was interviewed on the rise of wearable technology. The wearable market has seen an increase in “luxury” products as well as an expansion from wrist pieces to voice recorder necklaces, fitness tracker brooches and even rings that monitor

“The Connected World”: Intellectual Value Event – London

Please join us on 17 October when we will be hosting our annual Intellectual Value seminar – this year focusing on ‘The Connected World’ and a variety of topics from across the Internet of Things. From factories to offices, vehicles to homes, smart technologies are transforming every aspect of our society – and they’re here to stay. Businesses need

U.S. – What does the Impression Products v. Lexmark decision mean for drug companies? 5 takeaways

Last May, the U.S. Supreme Court issued a highly-anticipated decision in Impression Products, Inc. v. Lexmark Int’l, Inc., reversing the Federal Circuit and holding that, when a patent holder sells a product, it exhausts all of its patent rights in the product, regardless of certain restrictions that the patent holder sought to impose on further resale.

IP Newsletter – French language / Français

Our Paris team is delighted to provide IP news and updates in French language. The latest edition, #16 from September 2017 can be accessed at the link below. Lettre d’actualité IPMT – Français (French language)

IP is at the heart of life sciences innovation

In recent years, technology and innovation has advanced at an unprecedented pace. Flying taxi drones, self-driving cars and 3D-printers immediately come to mind. However, exciting progress has been made in life sciences and the healthcare sector as well. With CRISPR, bionic limbs and 3D-printed tissue, the medical sector has never been closer to eliminating disease

US: Bioprinting – A life sciences and legal innovation

The patent eligibility of bioprinted products and processes has not been squarely addressed by the legislature or tested in courts. Arlene Chow and Nitya Anand explain what could be done in the future in this article, first published in issue #35 of IPPro Patents. The medical industry is undergoing a radical transformation, thanks to recent

Major IP reforms foreshadowed in China’s Pharma sector.

On 12 May 2017, the Chinese Food and Drug Administration (the “CFDA”) issued several draft policies aimed at overhauling of the current regulations governing the Chinese pharma and medical device sector (the “Draft Policies”). Amongst the Draft Policies, those outlined in Circular No.55 would, if implemented, establish a more robust patent linkage system, a more

U.S. Patent Legislation: The STRONGER Patents Act of 2017

In June, three democratic senators (Chris Coons from Delaware, Dick Durbin from Illinois, and Mazie Hirono from Hawaii) and one republican senator (Tom Cotton from Arkansas) introduced the “STRONGER Patents Act of 2017.” One of the motivations for the bill appears to be that the U.S. Chamber of Commerce recently ranked the U.S. patent system

US: Update on pleading standards in patent cases

It has been nearly two years since the Federal Rules of Civil Procedure were amended to eliminate Form 18, the World War II-era sample form that authorized plaintiffs to commence patent infringement litigation with only bare-bones allegations. In the absence of Form 18, it is widely accepted that patent infringement complaints are now governed by

UK Supreme Court hands down landmark ruling in favour of Eli Lilly

Following last Friday’s (7 July 2017) unusual move of advance publication of the outcome of the case, the UK Supreme Court now published the reasons for its decision in the long-running Actavis v Eli Lilly case. The reasons show that the UKSC found for Lilly under every point being considered. The result is that Actavis’ products

Italian time-machine : Limitation of the duration of an SPC may be decided by the Italian Patent Office

The Board of Appeal of the Italian Patent Office (Commissione dei Ricorsi), by decision published on June 26, 2017, acknowledged the right of the patent holder to ask the Italian Patent Office for the limitation of the duration of a supplementary protection certificate (SPC) further to its recalculation on account of an earlier marketing authorisation. Background

Hogan Lovells Successfully Acts for Eli Lilly in UK Supreme Court Patent Ruling

In an unusual move, the UK Supreme Court (UKSC) has given its key conclusions in the long running Actavis v Eli Lilly case ahead of giving the full judgment. The UKSC allowed Eli Lilly’s appeal and held that Actavis’ products directly infringe Lilly’s patent in the United Kingdom, France, Italy and Spain. The full judgment

Court of Milan rules on interim measure ordering the halt of the pricing and reimbursement procedure of a generic product

By order issued on June 18, 2017, in summary proceedings brought by Teva against Mylan and Synthon for the alleged infringement of EP 2 361 924 (covering a manufacturing process for the active ingredient glatiramer acetate), the Court of Milan revoked the interim measure granted inaudita altera parte (i.e. without the defendants have been previously

US: Supreme Court takes up constitutionality of inter partes review

On June 12, 2017, the Supreme Court granted certiorari to decide the constitutionality of inter partes review, a proceeding before the Patent Trial and Appeals Board (PTAB) that allows third parties, typically alleged infringers, to challenge the validity of issued patents.  The question presented in Oil States Energy Services, LLC v. Greene’s Energy Group, LLC

A rising star at Euromoney LMG Europe Women in Business Law Awards 2017

We are excited to announce that Miriam Gundt received the Rising star: IP award during this month’s award ceremony in London. Alongside this award, Cecile Derycke was awarded Best in Product Liability. In addition to these categories, the LMG Europe Women in Business Law Awards recognize the best lawyer in each practice area as well as firm awards celebrating the best

U.S. Energy disputes: Patents or trade secrets? Yes, please.

Most energy companies implement Intellectual Property (“IP”) strategies to protect and exploit company IP (offense) and navigate third-party rights (defense). Traditionally, these policies emphasize patents. But today’s IP-savvy energy companies strategically manage both patent and trade secret portfolios throughout a company’s particular energy sector focus. The ascendance of trade secrets reflects recent strengthening of U.S.

Blockchain Technology: what can it do for you?

What is Blockchain? What are the practical uses and legal implications resulting from it? Hogan Lovells invites you to participate in its sixth TMT seminar dedicated to blockchain on: Thursday 22nd of June, from 5:30PM – Hogan Lovells Paris Office Join us for a discussion on the following topic: “Blockchain: views of an IT specialist and

IP Newsletter – French language/Français

Our Paris team is delighted to provide IP news and updates in French language. The latest edition, #15 from May 2017 can be accessed at the link below. Lettre d’actualité IPMT – Français (French language)

US: Our patent lawyers speaking at 2017 Rocky Mountain IP & Tech Law Institute

We are proud to be sponsoring and speaking at the 15th Annual Rocky Mountain IP & Technology Law Institute. The June 1-2, 2017 event in Denver, Colorado brings together national practice and thought leaders, along with PTO and PTAB representatives, for special plenary sessions and networking. Two of our patent lawyers will represent the Denver